258 related articles for article (PubMed ID: 36330628)
1. Medicinal Chemistry of Pyrazolopyrimidine Scaffolds Substituted with Different Heterocyclic Nuclei.
Elgemeie GH; Azzam RA; Zaghary WA; Khedr MA; Elsherif GE
Curr Pharm Des; 2022; 28(41):3374-3403. PubMed ID: 36330628
[TBL] [Abstract][Full Text] [Related]
2. An assessment study of known pyrazolopyrimidines: Chemical methodology and cellular activity.
Rao RN; Chanda K
Bioorg Chem; 2020 Jun; 99():103801. PubMed ID: 32278206
[TBL] [Abstract][Full Text] [Related]
3. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
4. Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.
Asati V; Anant A; Patel P; Kaur K; Gupta GD
Eur J Med Chem; 2021 Dec; 225():113781. PubMed ID: 34438126
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 3-substituted pyrazolopyrimidine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors.
Zheng N; Pan J; Hao Q; Li Y; Zhou W
Bioorg Med Chem; 2018 May; 26(8):2165-2172. PubMed ID: 29567295
[TBL] [Abstract][Full Text] [Related]
7. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
Nehra B; Mathew B; Chawla PA
Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
[TBL] [Abstract][Full Text] [Related]
8. 1,3-Thiazole Derivatives as a Promising Scaffold in Medicinal Chemistry: A Recent Overview.
Kushwaha P; Pandey S
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(3):133-163. PubMed ID: 37997807
[TBL] [Abstract][Full Text] [Related]
9. New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: Synthesis, anticancer, antimicrobial evaluation and computational studies.
Othman IMM; Alamshany ZM; Tashkandi NY; Gad-Elkareem MAM; Anwar MM; Nossier ES
Bioorg Chem; 2021 Sep; 114():105078. PubMed ID: 34161878
[TBL] [Abstract][Full Text] [Related]
10. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
Abdallah AEM; Elgemeie GH
Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, and
Mandour AA; Nassar IF; Abdel Aal MT; Shahin MAE; El-Sayed WA; Hegazy M; Yehia AM; Ismail A; Hagras M; Elkaeed EB; Refaat HM; Ismail NSM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1957-1973. PubMed ID: 35815597
[TBL] [Abstract][Full Text] [Related]
12. Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Ali EMH; Abdel-Maksoud MS; Oh CH
Bioorg Med Chem; 2019 Apr; 27(7):1159-1194. PubMed ID: 30826188
[TBL] [Abstract][Full Text] [Related]
13. The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021.
Liang T; Yang Y; Wang J; Xie Z; Chen X
Mini Rev Med Chem; 2023; 23(10):1118-1136. PubMed ID: 36635929
[TBL] [Abstract][Full Text] [Related]
14. A Comprehensive Review on Journey of Pyrrole Scaffold Against Multiple Therapeutic Targets.
Mir RH; Mir PA; Mohi-Ud-Din R; Sabreen S; Maqbool M; Shah AJ; Shenmar K; Raza SN; Pottoo FH
Anticancer Agents Med Chem; 2022; 22(19):3291-3303. PubMed ID: 35702764
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of some novel fused pyrazolopyrimidines as potential anticancer and antimicrobial agents.
Abd El Razik HA; Wahab AE
Arch Pharm (Weinheim); 2011 Mar; 344(3):184-96. PubMed ID: 21384418
[TBL] [Abstract][Full Text] [Related]
16. Key Updates on the Chemistry and Biological Roles of Thiazine Scaffold: A Review.
Choudhary S; Silakari O; Singh PK
Mini Rev Med Chem; 2018; 18(17):1452-1478. PubMed ID: 29663882
[TBL] [Abstract][Full Text] [Related]
17. Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activities.
Shao H; Shi S; Huang S; Hole AJ; Abbas AY; Baumli S; Liu X; Lam F; Foley DW; Fischer PM; Noble M; Endicott JA; Pepper C; Wang S
J Med Chem; 2013 Feb; 56(3):640-59. PubMed ID: 23301767
[TBL] [Abstract][Full Text] [Related]
18. An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.
He M; Fan M; Peng Z; Wang G
Eur J Med Chem; 2021 Oct; 221():113546. PubMed ID: 34023737
[TBL] [Abstract][Full Text] [Related]
19. Imidazo[1,2-b]pyridazine as privileged scaffold in medicinal chemistry: An extensive review.
Garrido A; Vera G; Delaye PO; Enguehard-Gueiffier C
Eur J Med Chem; 2021 Dec; 226():113867. PubMed ID: 34607244
[TBL] [Abstract][Full Text] [Related]
20. Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities.
Ghith A; Ismail NSM; Youssef K; Abouzid KAM
Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 29027246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
